Neelam A, Kanaki A. Efficacy and safety of remogliflozin etabonate in type 2 diabetes mellitus patients in a tertiary care hospital. Int J Basic Clin Pharmacol [Internet]. 2021 Mar. 22 [cited 2025 Oct. 23];10(4):353-6. Available from: https://www.ijbcp.com/index.php/ijbcp/article/view/4535